*Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida; and
†Department of Bioengineering, University of Washington, Seattle, Washington.
Reprint requests: Philip J. Rosenfeld, MD, PhD, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, 900 NW 17th Street, Miami, FL 33136; e-mail: [email protected]
Supported by grants from Carl Zeiss Meditec, Inc. (Dublin, CA), National Eye Institute (R01EY028753), the Salah Foundation (Ft. Lauderdale, FL), an unrestricted grant (GR004596) from the Research to Prevent Blindness, Inc (New York, NY) and the National Eye Institute Center Core Grant (P30EY014801) to the Department of Ophthalmology, University of Miami Miller School of Medicine. The funding organizations had no role in the design or conduct of this research. J. F. Russell was supported in part by a Heed Fellowship.
G. Gregori, P. J. Rosenfeld, and R. K. Wang received research support from Carl Zeiss Meditec, Inc. G. Gregori and the University of Miami co-own a patent that is licensed to Carl Zeiss Meditec, Inc. P. J. Rosenfeld also received additional research support from Stealth BioTherapeutics; consultancy for Apellis, Bayer, Boehringer-Ingelheim, Carl Zeiss Meditec, Chengdu Kanghong Biotech, Ocudyne, Ocunexus Therapeutics, Regeneron, and Unity Biotechnology; equity interests in Apellis, Valitor, Verana Health, and Ocudyne. R. K. Wang has intellectual property owned by the Oregon Health and Science University and the University of Washington related to OCT angiography, which are licensed to commercial entities and related to the technology and analysis methods used in this manuscript. He is a consultant to Carl Zeiss Meditec, Inc. The other authors have no conflicting interests to disclose.
